Share

CLINICAL TRIAL SEARCH RESULTS

NEW SEARCH
 Number: 201204071 Principal Investigator: Wagner-Johnston, Nina
Title: A Phase I/II Institutional Study of Abraxane in Recurrent and Refractory Lymphoma
Description: The purpose of this research study is to find the maximum tolerated dose for Abraxane as well as discover what side effects are associated with its use in patients with lymphoma and how the disease responds to Abraxane....MORE
___________________________________________________________________________________________________
 Number: 201010719 Principal Investigator: Fehniger, Todd
Title: A Pilot Study of Lenalidomide Maintenance Therapy Following Autologous Stem Cell Transplantation in Patients with Relapsed/Refractory Hodgkin Lymphoma
Description: The purpose of this research study is to gather information about lenalidomide maintenance therapy in patients with classical Hodgkin lymphoma....MORE
___________________________________________________________________________________________________
 Number: 201110234 Principal Investigator: Bartlett, Nancy
Title: A Phase I/II Trial of Panobinostat and lenalidomide in Patients with Relapsed or Refractory Hodgkin's Lymphoma
Description: The goal of this clinical research study is to find out the effects of the drugs called panobinostat and lenalidomide when given in combination to people with Hodgkin’s lymphoma. The safety of this combination of drugs will also be studied....MORE
___________________________________________________________________________________________________
 Number: CALGB 50801 Principal Investigator: Bartlett, Nancy
Title: Phase II Trial of Response-Adapted Therapy Based on Position Emission Tomography (PET) for Bulky Stage I and Stage II Classical Hodgkin Lymphoma (HL)
Description: The purpose of this study is to find out if we can safely reduce the total number of cycles of chemotherapy that patients will need for their Hodgkin lymphoma based on their response during treatment as seen on positron emission tomography (PET) scan images. This research is being done in order ...MORE
___________________________________________________________________________________________________
 Number: 201404019 Principal Investigator: Bartlett, Nancy
Title: A Phase I Study of Positron Emission Tomography (PET) Imaging with 89Zr-Df-IAB27FA in Patients with Hodgkin Lymphoma (HL), Anaplastic Large Cell Lymphoma (ALCL), and Diffuse Large B-Cell Lymphoma (DLBCL) (2013-27F-0001)
Description: The purpose of this research study is to determine the safety of 89Zr-Df-IAB27FA, to see what the body does with 89Zr-Df-IAB27FA and where 89Zr-Df-IAB27FA is distributed within the body for patients with classical Hodgkin Lymphoma (cHL), systemic Anaplastic Large Cell Lymphoma (sALCL) and Diffuse La...MORE
___________________________________________________________________________________________________
 Number: 201210128 Principal Investigator: Bartlett, Nancy
Title: A Randomized, Open-label, Phase 3 Trial of A+AVD Versus ABVD as Frontline Therapy in Patients With Advanced Classical Hodgkin Lymphoma (C25003)
Description: The purpose of this research study is to compare how well two different treatments work. In this study, patients will receive either a treatment that includes the investigational drug called brentuximab vedotin or a commonly prescribed treatment that does not contain brentuximab vedotin....MORE
___________________________________________________________________________________________________